Effect of the format of antibodies on their specificity

Molecular Immunology

Volumn 49, Issue 3, 2011, Pages 433-440

  Shepelyakovskaya, A O ^a   Laman, A G ^a   Lomonosova, A V ^a   Fursova, K K ^a   Savinov, G V ^a   Vertiev, Yu V ^b   Brovko, F A ^a,c   Grishin, E V ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Constant domains; Cross reactivity of antibodies; Format of antibodies; Phage antibodies; ScFv; Staphylococcus enterotoxins

Indexed keywords

ANTIGEN; MONOCLONAL ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN;

ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; GENETIC TRANSFORMATION; PRIORITY JOURNAL;

ANIMALS; ANTIBODY SPECIFICITY; CROSS REACTIONS; ENTEROTOXINS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MICE; STAPHYLOCOCCUS;

MURINAE; STAPHYLOCOCCUS;

EID: 81955167455     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.09.017     Document Type: Article

References (33)

1. Bavari S., Ulrich R.G., LeClaire R.D. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens. J. Infect. Dis. 1991, 180:365-369.
2. Bostrom J., Yu S.F., Kan D., Appleton B.A., Lee C.V., Billeci K., Man W., Peale F., Ross S., Wiesmann C., Fuh G. Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. Science 2009, 323:1610-1614.
3. Carter P. Potent antibody therapeutics by design. Nat. Rev. Immunol. 2006, 6:343-357.
4. Chowdhury P.S., Wu H. Tailor-made antibody therapeutics. Methods 2005, 36:11-24.
5. Daly S., Dillon P., Manning B., Dunne L., Killard A., O'Kennedy R. Production and characterization of murine single chain Fv antibodies to aflatoxin b 1 derived from a pre-immunized antibody phage display library system. Food Agric. Immunol. 2002, 14:255-274.
6. Deshmukh U.S, Bagavant H., Lewis J., Gaskin F., Fu S.M. Epitope spreading within lupus-associated ribonucleoprotein antigens. Clin. Immunol. 2005, 117:112-120.
7. Dimasi N., Gao C., Fleming R., Woods R., Yao X., Shirinian L., Kiener P., Wu H. J. Mol. Biol. 2009, 393:672-692.
8. Ewert S., Honegger A., Pluckthun A. Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering. Methods 2004, 34:184-199.
9. Fraser J.D., Proft T. The bacterial superantigen and superantigen-like proteins. Immunol. Rev. 2008, 225:226-243.
10. Friguet B., Chaffotte A.F., Djavadi-Ohaniance L., Goldberg M.E. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods 1985, 77:305-319.
11. Fursova K.K., Laman A.G., Melnik B.S., Semisotnov G.V., Kopylov P.Kh., Kiseleva N.V., Nesmeyanov V.A., Brovko F.A. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2009, 877:2045-2051.
12. Garcia-Rodriguez C., Levy R., Arndt J.W., Forsyth C.M., Razai A., Lou J., Geren I., Stevens R.C., Marks J.D. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat. Biotechnol. 2007, 25:107-116.
13. Gerstenbruch S., Cory, Brooks L., Kosma P., Brade L., MacKenzie R., Evans S., Brade H., Muller-Loennies S. Glycobiology 2010, 20:461-472.
14. Goldman E.R., Hayhurst A., Lingerfelt B.M., Iverson B.L., Georgiou G., Anderson G.P. 2,4,6-Trinitrotoluene detection using recombinant antibodies. J. Environ. Monit. 2003, 3:380-383.
15. Guo J.Q., You H.Y., Li L., Zhang Y.Z., Huang J.N., Zhang Ch.Y. Construction and high-level expression of a single-chain Fv antibody fragment specific for acidic isoferritin in Escherichia coli. J. Biotechnol. 2003, 102:177-189.
16. James L.C., Roversi P., Tawfik D.S. Antibody multispecificity mediated by conformational diversity. Science 2003, 299:1362-1367.
17. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y. Infections and autoimmunity-friends or foes?. Trends Immunol. 2009, 8:409-414.
18. Larkin E.A., Carman R.J., Krakauer T., Stiles B.G. Staphylococcus aureus: the toxic presence of a pathogen extraordinaire. Curr. Med. Chem. 2009, 30:4003-4019.
19. Oppermann M. Anion exchange chromatography for purification of monoclonal IgG antibodies. Monoclonal Antibodies 1992, 271-274. Springer Laboratory, Berlin. J.H. Peters, Baumgarten (Eds.).
20. Pope A., Pritchard K., Williams A., Roberts A., Hackett J.R., Mandecki W., Johnson K.S. In vitro selection of a high affinity antibody to oestradiol using a phage display human antibody library. Immunotechnology 1996, 2:209-217.
21. Presta L. Evolving an anti-toxin antibody. Nat. Biotechnol. 2007, 25:63-65.
22. Riaño-Umbarila L., Gabriel Contreras-Ferrat G., Timoteo Olamendi-Portugal T., Morelos-Juarez C., Corzo G., Possani L.D., Becerril B. Exploiting cross-reactivity to neutralize two different scorpion venoms with one single-chain antibody fragment. J. Biol. Chem. 2011, 286:6143-6151.
23. Rubina A., Yu, Filippova M.A., Feizkhanova G.U., Shepeliakovskaya A.O., Sidina E.I., Boziev Kh.M., Laman A.G., Brovko F.A., Vertiev Yu.V., Zasedatelev A.S., Grishin E.V. Simultaneous detection of seven Staphylococcal enterotoxins: development of hydrogel biochips for analytical and practical application. Anal. Chem. 2010, 82:8881-8889.
24. Strasser A., Puthalakath H., O'Reilly L.A., Bouillet P. What do we know about the mechanisms of elimination of autoreactive T and B cells and what challenges remain. Immunol. Cell Biol. 2008, 86(1):57-66.
25. Sundberg E.J., Deng L., Mariuzza R.A. TCR recognition of peptide/MHC class II complexes and superantigens. Semin. Immunol. 2007, 19:262-271.
26. Thomas D., Chou S., Dauwalder O., Lina G. Diversity in Staphylococcus aureus enterotoxins. Superantigens and Superallergens 2007, 93:24-41. Karger, Basel, (Chem. Immunol. Allergy).
27. Tonegawa S. Somatic generation of antibody diversity. Nature 1983, 302:575-581.
28. Ulitin A.B., Kapralova M.V., Laman A.G., Shepelyakovskaya A.O., Bulgakova E.V., Fursova K.K., Abbasova S.G., Volkov S.K., Brovko F.A., Nesmeyanov V.A. The library of human miniantibodies in the phage display format: designing and testing. Dokl. Biochem. Biophys. 2005, 405:437-440.
29. Varga J.M., Kalchschmid G., Klein G., Fritsch P. Mechanism of allergic cross-reaction - I. Multispecific binding of ligands to mouse monoclonal anti-DNP IgE antibody. Mol. Immunol. 1991, 28:641-654.
30. Weisser N.E., Hall J.C. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics. Biotechnol. Adv. 2009, 27:502-520.
31. Yin J., Beuscher A.E., Andryski S.E., Stevens R.C., Schultz P.G. Structural plasticity and the evolution of antibody affinity and specificity. J. Mol. Biol. 2003, 330(4):651-656.
32. Yuan Q., Clarke J.R., Zhou H.R., Linz J.E., Pestka J.J., Hart L.P. Molecular cloning, expression, and characterization of a functional single-chain Fv antibody to the mycotoxin zearalenone. Appl. Environ. Microbiol. 1997, 63(1):263-269.
33. Zhou Z.H., Tzioufas A.G., Notkins A.L. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J. Autoimmun. 2007, 29:219-228.